JHS Svendgaard Laboratories Ltd Stock Price Today (NSE: JHS)
Fundamental Score
JHS Svendgaard Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
JHS Svendgaard Laboratories Ltd share price today is ₹8.10, up +1.25% on NSE/BSE as of 17 June 2026. JHS Svendgaard Laboratories Ltd (JHS) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹94.41 (Cr). The 52-week high for JHS share price is ₹13.90 and the 52-week low is ₹6.26. The company has a Return on Equity (ROE) of -10.84% and a debt-to-equity ratio of 0.06.
JHS Svendgaard Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance
JHS Svendgaard Laboratories Ltd share price chart: 1.20% return over the past month. 52-week high ₹13.90, 52-week low ₹6.26.
JHS Svendgaard Laboratories Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹9.20 | ₹9.20 | ₹8.64 | ₹8.67 | 13.12K (Cr) | |
| ₹9.03 | ₹9.44 | ₹8.75 | ₹8.85 | 41.54K (Cr) | |
| ₹9.30 | ₹9.30 | ₹9.00 | ₹9.03 | 26.13K (Cr) | |
| ₹9.52 | ₹9.53 | ₹9.05 | ₹9.30 | 2.10L (Cr) | |
| ₹8.97 | ₹9.08 | ₹8.40 | ₹9.08 | 3.07L (Cr) | |
| ₹8.55 | ₹8.95 | ₹8.45 | ₹8.65 | 80.35K (Cr) | |
| ₹8.70 | ₹8.75 | ₹8.35 | ₹8.58 | 38.20K (Cr) | |
| ₹8.97 | ₹8.97 | ₹8.25 | ₹8.37 | 31.55K (Cr) | |
| ₹8.42 | ₹8.64 | ₹8.33 | ₹8.55 | 4.16K (Cr) | |
| ₹8.49 | ₹8.65 | ₹8.25 | ₹8.42 | 34.70K (Cr) |
JHS Svendgaard Laboratories Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹9.03 | ₹9.44 | ₹8.64 | ₹8.67 | -3.99% | |
| ₹9.15 | ₹9.53 | ₹8.25 | ₹9.03 | -1.31% | |
| ₹6.81 | ₹9.77 | ₹6.78 | ₹8.85 | +29.96% | |
| ₹9.02 | ₹9.99 | ₹6.26 | ₹6.55 | -27.38% | |
| ₹10.50 | ₹12.00 | ₹9.00 | ₹9.50 | -9.52% | |
| ₹9.99 | ₹12.90 | ₹8.66 | ₹10.48 | +4.90% | |
| ₹10.89 | ₹11.78 | ₹9.25 | ₹9.82 | -9.83% | |
| ₹13.26 | ₹13.40 | ₹10.18 | ₹10.72 | -19.16% | |
| ₹10.71 | ₹13.90 | ₹10.71 | ₹13.00 | +21.38% | |
| ₹11.08 | ₹12.73 | ₹10.50 | ₹10.85 | -2.08% | |
| ₹12.99 | ₹12.99 | ₹10.02 | ₹10.77 | -17.09% | |
| ₹13.25 | ₹13.54 | ₹12.23 | ₹12.64 | -4.60% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Micro-cap oral care contract manufacturer faces brutal headwinds; avoid until execution improves.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The stock is currently Recent news includes compliance filings and a newspaper publication regarding re-lodgment of physical shares.
CORE STORY (THE REAL GAME)
JHS Svendgaard is a contract manufacturer in the oral care space, attempting to transition from a micro-cap commodity player to a higher-margin, innovation-led manufacturer with a global footprint. The market is trying to figure out if they can execute.
- Expansion into US market with GuruNanda
- Investment in new manufacturing facility
- Overall growth in Indian personal care market
- Significant order wins
- Positive earnings surprise
- Successful ramp-up of new manufacturing facility
- Micro-cap with high liquidity risk
- Negative free cash flow and profitability metrics
- Negative sales CAGR
FII decreased slightly by 0.02%.
Indian beauty and personal care market is growing at a CAGR of 5.08%.
Company is investing ₹25 crore in a new manufacturing unit in Himachal Pradesh.
No, Free Cash Flow 5Y: ₹-36.74 Cr
Next 3-6 months will be critical to see if expansion plans materialize and if the GuruNanda partnership gains traction. Need to see significant improvement in financial metrics before considering a positive outlook.
Primary Thesis Risk
Inability to execute expansion plans and generate positive cash flow will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
JHS Svendgaard Laboratories Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
JHS Svendgaard Laboratories Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JHS across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (98.06%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-10.84%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-5.19%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-2.96%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Limited Growth History (-7.94% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-9.23x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-36.74 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.57%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
JHS Svendgaard Laboratories Ltd vs Personal Care Peers
Peer Comparison - Personal Care
Compare JHS Svendgaard Laboratories Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
13.3/100 | ₹8.10₹8 | ₹94.41₹94.41 | — — | -10.84%Poor -10.84% Poor | -5.19%Poor -5.19% Poor | 0.06Excellent 0.1 Excellent | — — | -7.94%Poor -7.94% Poor | 0.00% | |
Godrej Consumer Products LtdGodrej Consumer... GODREJCP • 532424 | 42.9/100 | ₹1022.00₹1022 | ₹115504.75₹115504.75 | 61.35Average 61.4 Average | 15.21%Good 15.21% Good | 19.21%Good 19.21% Good | 0.34Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 7.70%Good 7.70% Good | 1.33% |
Dabur India LtdDabur India Ltd... DABUR • 500096 | 45.3/100 | ₹445.45₹445 | ₹91407.05₹91407.05 | 50.53Average 50.5 Average | 17.04%Good 17.04% Good | 20.24%Excellent 20.24% Excellent | 0.12Excellent 0.1 Excellent | 3.01%Average 3.01% Average | 7.66%Good 7.66% Good | 1.55% |
Colgate Palmolive India LtdColgate Palmoli... COLPAL • 500830 | 53.3/100 | ₹2087.40₹2087 | ₹58477.58₹58477.58 | 44.10Average 44.1 Average | 81.19%Excellent 81.19% Excellent | 105.34%Excellent 105.34% Excellent | 0.04Excellent 0.0 Excellent | 11.96%Good 11.96% Good | 5.95%Good 5.95% Good | 2.37% |
Procter & Gamble Hygiene LimitedProcter & Gambl... PGHH • 500459 | 49.3/100 | ₹9706.00₹9706 | ₹41537.66₹41537.66 | 50.25Average 50.3 Average | 75.67%Excellent 75.67% Excellent | 103.79%Excellent 103.79% Excellent | 0.00Excellent 0.0 Excellent | 8.44%Good 8.44% Good | 2.75%Average 2.75% Average | 0.86% |
Gillette India LtdGillette India ... GILLETTE • 507815 | 54.7/100 | ₹7662.50₹7663 | ₹27967.94₹27967.94 | 48.73Average 48.7 Average | 41.62%Excellent 41.62% Excellent | 56.06%Excellent 56.06% Excellent | 0.00Excellent 0.0 Excellent | 10.45%Good 10.45% Good | 3.72%Average 3.72% Average | 1.31% |
Emami LtdEmami Ltd... EMAMILTD • 531162 | 57.2/100 | ₹435.05₹435 | ₹22959.79₹22959.79 | 30.46Average 30.5 Average | 30.18%Excellent 30.18% Excellent | 32.42%Excellent 32.42% Excellent | 0.02Excellent 0.0 Excellent | 21.30%Excellent 21.30% Excellent | 7.49%Good 7.49% Good | 1.52% |
Cupid LtdCupid Ltd... CUPID • 530843 | 32.5/100 | ₹128.90₹129 | ₹9372.27₹9372.27 | 151.83Average 151.8 Average | 12.89%Average 12.89% Average | 17.10%Good 17.10% Good | 0.07Excellent 0.1 Excellent | 0.89%Average 0.89% Average | 2.70%Average 2.70% Average | 0.00% |
Honasa Consumer LtdHonasa Consumer... HONASA • 544014 | 51.3/100 | ₹354.50₹355 | ₹9315.44₹9315.44 | 74.86Average 74.9 Average | 5.51%Poor 5.51% Poor | 7.44%Poor 7.44% Poor | 0.09Excellent 0.1 Excellent | 16.54%Excellent 16.54% Excellent | 76.22%Excellent 76.22% Excellent | 0.00% |
Bajaj Consumer Care LtdBajaj Consumer ... BAJAJCON • 533229 | 58.3/100 | ₹560.75₹561 | ₹3635.38₹3635.38 | 26.63Average 26.6 Average | 15.70%Good 15.70% Good | 19.06%Good 19.06% Good | 0.03Excellent 0.0 Excellent | -7.53%Poor -7.53% Poor | 2.51%Average 2.51% Average | 0.00% |
Anondita MediAnondita Medi... ANONDITA • | 33.7/100 | ₹1013.25₹1013 | ₹1191.73₹1191.73 | 51.90Average 51.9 Average | — — | — — | 0.43Excellent 0.4 Excellent | — — | — — | 0.00% |
Top Personal Care Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Consumer Products Ltd share price115504.75 Cr
- Dabur India Ltd share price91407.05 Cr
- Colgate Palmolive India Ltd share price58477.58 Cr
- Procter & Gamble Hygiene Limited share price41537.66 Cr
- Gillette India Ltd share price27967.94 Cr
JHS Svendgaard Laboratories Ltd Quarterly Performance
Latest quarterly metrics for JHS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
13.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
98.06%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-7.94%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
JHS Svendgaard Laboratories Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for JHS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
JHS Svendgaard Laboratories Ltd Financial Statements
Annual income statement, balance sheet and cash flow for JHS Svendgaard Laboratories Ltd (JHS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for JHS Svendgaard Laboratories Ltd
About JHS (JHS Svendgaard Laboratories Ltd)
JHS Svendgaard Laboratories Ltd is a prominent player in the Indian personal care market, specializing in the creation and distribution of a diverse portfolio of oral and dental hy...giene essentials. With a strong focus on innovation and quality, JHS crafts a comprehensive range of products designed to cater to the everyday needs of consumers. Their offerings span from essential toothbrushes and invigorating toothpastes to refreshing mouthwashes, ensuring a complete oral care routine. The company's commitment extends beyond basic hygiene, venturing into specialized products like teeth whitening gels and denture care tablets, showcasing their dedication to addressing specific consumer demands within the oral health sector. Beyond oral care, JHS Svendgaard Laboratories demonstrates its adaptability by extending its expertise to other personal care segments. The company manufactures and markets a range of products including gentle talcum powders, hand sanitizers, and versatile detergents, reflecting a holistic approach to hygiene and well-being. This diversification allows JHS to reach a broader consumer base and establish a stronger foothold in the competitive personal care market. By consistently innovating and expanding its product lines, JHS Svendgaard Laboratories aims to become a trusted household name, synonymous with quality and reliability in personal care solutions. Moreover, JHS Svendgaard Laboratories actively participates in the global market through its export operations, further solidifying its presence and reach. The company's commitment to maintaining international standards of quality and manufacturing allows it to successfully compete in diverse markets. In addition to its own branded products, JHS also offers contract manufacturing services for oral care products, leveraging its state-of-the-art facilities and expertise to support other brands in the industry. This dual approach, combining proprietary products with contract manufacturing, positions JHS Svendgaard Laboratories as a versatile and reliable partner in the personal care sector, driving growth and innovation across the industry.
Company Details
Key Leadership
Corporate Events
JHS Share Price: Frequently Asked Questions
What is the current share price of JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd (JHS) trades at ₹8.10 on NSE and BSE. Market cap ₹94.41 (Cr). Educational data only.
What is the P/E ratio of JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd has a P/E of N/Ax vs industry average 50.39x.
What is the Bull Run score for JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd has a Bull Run score of 13.3/100 based on 25+ financial parameters.
Does JHS Svendgaard Laboratories Ltd pay dividends?
JHS Svendgaard Laboratories Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd has ROE of -10.84%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd has debt-to-equity of 0.06.
Is JHS Svendgaard Laboratories Ltd a good investment?
Bull Run gives JHS Svendgaard Laboratories Ltd a score of 13.3/100. This is not investment advice — consult a SEBI-registered advisor.